CMS Targeting LTC Facility Overprescribing, Citing Antipsychotics
Executive Summary
The Centers for Medicare and Medicaid Services is proposing a new Medicare requirement that consulting pharmacists serving long-term care facilities maintain independence from the facility to help avoid drug “overprescribing and overutilization.”
You may also be interested in...
CMS Initiative To Lower Antipsychotic Drug Use In Nursing Homes Showing Success
A program launched in 2012, the National Partnership to Improve Dementia Care, is on its way to meeting goals of lowering the use of antipsychotic drugs in nursing homes by 15%, with 11 states already hitting that target.
Nursing Home Overprescribing: CMS Urges Voluntary Remedies, Withholds Regulation
CMS will not implement an earlier regulatory proposal requiring that consultant pharmacists maintain independence from long-term care facilities or drug firms at this point.
Nursing Home Overprescribing: Pharmacist Independence Requirement Should Start As Demo, APhA Says
CMS’ proposal to reduce overprescribing in nursing homes draws cautiously favorable response from national pharmacist group, but long-term care pharmacy firm Omnicare argues the agency has not provided adequate justification for its plan.